
California ➡️ Ohio ➡️ North Carolina | OPAT/ID PharmD BCIDP @Firsthealth | Thoughts are my own 🐶🏂🍝
Joined January 2019
- Tweets125
- Following152
- Followers160
- Likes821
Last minute participation in #NationalHatDay
All the credit goes to my learner for her quick idea on making paper hats
1
69
Allison Cid retweeted
Is it time for global harmonization of opat drug stability testing frameworks? Great to collaborate with @jasonroberts_pk @b_fekade @CRE_RESPOND @raseaton66 @BSACandJAC & many more - onto the next step! academic.oup.com/jacamr/arti…
Happy antibiotic awareness week. Disclaimer: many viruses pictured, but remember antibiotics do not treat viruses! #USAAW24 #antibiotic
Allison Cid retweeted
Outpatient Parenteral Antimicrobial Therapy (OPAT) in a Safety-net Hospital: Opportunities for Improvement
✅ Just Accepted
🔓 Open Access
🔗 bit.ly/49EThTb
Allison Cid retweeted
Definitely team daptomycin for OPAT. Unfortunately, sometimes the copays are still too high for our patients. Especially Medicare patients since Medicare doesn’t cover OPAT well.
Inspired by a trio of outstanding @MGHBWHIDFellows, I'm writing about the antibiotic we love to hate, and hate to love -- vancomycin.
Very hard to justify it in the outpatient setting, where there are almost always safer and more convenient alternatives. blogs.jwatch.org/hiv-id-obse…
Allison Cid retweeted
Must read! 📖 New SIDP & @Contagion_Live Bench to Bedside 🧪 🧫 👩⚕️ where Drs. @CaraSlaton and Mohamed Hisham Basheer discuss role of non-carbapenem therapy for infected necrotizing pancreatitis!
Available here: buff.ly/48KzYXR
Allison Cid retweeted
🆕️🔥The largest real-world, multicenter study of dalbavancin use for Gram-positive BSI @NicholasRebold @IDpharmresearch and many @SIDPharm 🌟s
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection #IDXposts #DOTS
link.springer.com/article/10…
Allison Cid retweeted
💥CLSI M100 34rd Edition
Updates 👇 - A thread 🧵
#MicroRounds #IDXPosts #IDTwitter
(a bit late because I’m 🤒)
Allison Cid retweeted
Nearly 2x as much treatment failure at 14 days when using cefdinir, compared to cephalexin which has substantially better bioavailability and urinary concentrations in lower UTIs. Makes sense! #downwithcefdinir
Cefdinir V🔥 Cephalexin in lower UTI
🆕️⚡️⚡️Small retrospective study @AJHPOfficial
There were no significant differences in treatment failure at d7 or d14 between the agents
Numerically higher rate of treatment failure with cefdinir #downwithcefdinir
academic.oup.com/ajhp/advanc…
Allison Cid retweeted
🔥PUBLISHED 🔥 @TheLancetInfDis
Global guideline for the diagnosis and management of cryptococcosis:an initiative of the @eurconfmedmycol & @ISHAM_Mycology in cooperation @ASMicrobiology
🌟s @boulware_dr @martinhoenigl @FungalDoc @CornelyOliver @ferryhagen
thelancet.com/journals/lanin…
Allison Cid retweeted
Lots of new data coming out in the ID space lately 🔥🔥🔥 check out some of the new articles ⬇️:
SABATO 💉 vs. 💊: thelancet.com/journals/lanin…
REGARD-VAP 🫁: thelancet.com/journals/lanre…
#IDXPosts #IDTwitter
Allison Cid retweeted
Making the EHR work for you - Modifications of an Electronic Health Record System to Improve Tracking and Management of Patients Receiving Outpatient Parenteral Antibiotic Therapy
✅ Just Accepted
🔓 Open Access
🔗 bit.ly/3Stkzqg
@ssmunsiffIDdoc
More fuel to add to my anti-Cefdinir, pro-cephalexin for ecoli UTI fire 🔥
academic.oup.com/ofid/articl…
Allison Cid retweeted
Regular doses of tragedy and still responsible for 3x your normal workload? That was my 2020. Just like most of #IDTwitter. Talking about it was surprisingly therapeutic. Thanks @PaulSaxMD
New #LetsTalkID out now! idsociety.org/multimedia/pod…
ID doctor @GretchenArnoczy speaks to @PaulSaxMD about her piece in @CIDJournal’s Voice of ID series (bit.ly/3GYY7yk), which recounts her COVID professional experience through the lens of four consecutive Mothers’ Days.
Go check out our amazing resident posters now until 3 pm! PGY2 ED @BriannaPharmD is working on pharmacist-managed ED culture call back and @Kngodwin20 is improving stewardship for urine cultures to decrease unnecessary treatment of ASB! @FirstHealth #ASHP23
Allison Cid retweeted
Thanks to @MsSmallsO for highlighting our OPAT study at ASHP Midyear. @tayloreppp was the lead on this study looking at our OPAT program which showed reduced readmissions in patients discharged on vancomycin followed by a pharmacist in OPAT. pubmed.ncbi.nlm.nih.gov/3671…
Allison Cid retweeted
Great title -- really gets the message out there!
doi.org/10.1093/cid/ciad638
Pumpkin carving contest at work. I think our clinic rocked it!! #OPAT #Halloween2023
6
261
Allison Cid retweeted
@SIDPharm is excited to endorse the @ACCP International Consensus Recommendations for the Use of Prolonged-Infusion β-Lactams!
Review the guidance here: doi.org/10.1002/phar.2842
































